New research from Portland State University focused on identifying signs of life—biosignatures—in extreme environments here ...

In this installment of “LC Troubleshooting,” Dwight Stoll touches on highlights from Pittcon 2025 talks, as well as ...

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, March 25, 2025 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical ...

Nanogels improve drug delivery with controlled release and targeted systems, utilizing pH responsiveness and hybrid materials for enhanced therapeutic efficacy.

A pH neutral process would be safer and more environmentally ... The first trick: They constructed "micro batteries" in situ. These help to break up the spent cathode material from the batteries ...

For South Cotabato alone, MASIPAG’s Climate Change Resilient Rice Map said their members now have 29 locally-adapted ...

Driving through the heart of dairy country in the High Plains this past summer, one thing became clear—sorghum silage acres ...

This latest patent is part of Nirrin's expanding portfolio, reflecting the company's dedication to advancing real-time bioprocess analytics. By continuously developing groundbreaking technologies, ...

Gene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today announced that Ron Cooper, Chief Executive Officer, will present at the Stifel 2025 Virtual Targeted Oncology Forum, ...